Abstract Search

ea0070aep249 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

A multi-center, randomized, double-blind, parallel, active-controlled phase III clinical trial to evaluate the efficacy and safety of controlled-release pregabalin and immediate-release pregabalin in diabetic peripheral neuropathic pain

Hyuk lee Jae , Lee Min-Kyung , Im Hur Yang

Pregabalin is a highly used drug for the effective treatment of diabetic neuropathic pain. This study compared the efficacy and safety of a controlled-release (CR) Pregabalin tablet (GLA5PR GLARS-NF1) with an immediate-release (IR) Pregabalin capsuleafter 12 week administration in patients with diabetic peripheral neuropathy. In multicenter, randomized, double- blind, active- controlled, parallel- group, phase III study, the primary outcome was to confirm that CR pregabalin wi...

0 shares

Endocrine Abstracts

A multi-center, randomized, double-blind, parallel, active-controlled phase III clinical trial to evaluate the efficacy and safety of controlled-release pregabalin and immediate-release pregabalin in diabetic peripheral neuropathic pain

BiosciAbstracts